What is the Viscosupplementation Devices?
Viscosupplementation devices are gaining momentum in recent years. According to WHO, Osteoarthritis (OA) is a long-term chronic disease characterized by the deterioration of the cartilage in joints which results in bones rubbing together and creating stiffness, pain, and impaired movement. The disease most commonly affects the joints in the knees, hands, feet, and spine and is relatively common in the shoulder and hip joints.
Among all the types of osteoarthritis, knee osteoarthritis is the most prevalent among the old age population. For instance, as per the study published in Elsevier 2020, Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies, by Cui A. et al., the pooled global prevalence of knee OA was 16.0% (in individuals aged 15 and over) and was 22.9% among individuals aged 40 and over. Correspondingly, there were around 654.1 million individuals (40 years and older) with knee OA in 2020 worldwide.
Do you know about Viscosupplementation Devices Market Size?
Moreover, according to the Australian Institute of Health and Welfare 2020 report, between the years 2017 to 2018, one in eleven Australians have osteoarthritis which makes approximately 2.2 million people in the nation. Therefore, rising osteoarthritis among the population is likely to surge the global viscosupplementation devices market as these devices help reduce pain and swelling in the arthritic/osteoarthritic joint (most commonly, the knee).
Recently in 2019, Fidia Farmaceutici S.p.A. received Food & Drug Administration (FDA) regulatory approval for TRILURON™, a single-use syringe, prefilled with sodium hyaluronate to provide relief to the pain associated with osteoarthritis for up to six months. Thus, growing product approvals is also projected to boost the global market for the viscosupplementation market.
Certain factors such as the high cost associated with hyaluronic acid therapy and lack of efficiency of the viscosupplementation devices are expected to pose a challenge to the viscosupplementation devices market growth.
Learn For More Information– Viscosupplementation Devices Market Share
Latest Pharmaceuticals Reports by Delveinsight
4. Chronic smell and flavor loss Market
5. Thymidine Kinase 2 Deficiency Market
7. Systemic Inflammatory Response Syndrome Market
8. Advanced Liver Cancer Market
0
